Shengnan Wang
- Cancer Research top 10%
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 3
- Neurology top 10%
-
- Traditional Chinese Medicine Analysis 3
-
- Natural product bioactivities and synthesis 12
- Plant biochemistry and biosynthesis 4
- Metabolomics and Mass Spectrometry Studies 3
-
- Phytochemistry and Biological Activities 8
-
- Pharmacological Effects of Natural Compounds 4
In The Last Decade
Shengnan Wang
41 papers receiving 709 citations
Peers
Comparison fields: 5 of 108
- Cancer Research 168
- Neurology 77
- Complementary and alternative medicine 65
- Biological Psychiatry 19
- Molecular Biology 378
Countries citing papers authored by Shengnan Wang
This map shows the geographic impact of Shengnan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengnan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengnan Wang more than expected).
Fields of papers citing papers by Shengnan Wang
This network shows the impact of papers produced by Shengnan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengnan Wang. The network helps show where Shengnan Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shengnan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 2 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 17 | |
| 10 | 2022 | 8 | |
| 11 | 2021 | 40 | |
| 12 | 2020 | 19 | |
| 13 | 2020 | 10 | |
| 14 | 2019 | 71 | |
| 15 | 2019 | 3 | |
| 16 | Analysis of chemical constituents in male flowers of Eucommia ulmoides by liquid chromatography coupled with electrospray ionization-triple quadrupole-time of flight-tandem mass spectrometry (LC-ESI-Triple TOF-MS/MS). | 2018 | 2 |
| 17 | 2017 | 17 | |
| 18 | 2016 | 37 | |
| 19 | 2016 | 10 | |
| 20 | 2016 | 15 |
About Shengnan Wang
Shengnan Wang is a scholar working on Cancer Research, Pharmacology and Molecular Biology, having authored 42 papers that have together received 718 indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (12 papers), Phytochemistry and Biological Activities (8 papers), MicroRNA in disease regulation (4 papers), Pharmacological Effects of Natural Compounds (4 papers), Plant biochemistry and biosynthesis (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Traditional Chinese Medicine Analysis (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Cancer Research (168 citations), Neurology (77 citations) and Complementary and alternative medicine (65 citations). Shengnan Wang has collaborated with scholars based in China, Hong Kong and Taiwan. Frequent co-authors include Xunhong Liu, Lisi Zou, Qiuhe Chen, Yifan Han, Rongbiao Pi, Jingkao Chen, Xiaohong Yang, Yalin Tu, Juanxiu Liu and Ying Yan. Their work appears in journals such as Molecules, Journal of Chromatographic Science, Journal of Separation Science, Natural Product Communications and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.